Fisher Asset Management, LLC - Antibe Therapeutics, Inc.(Rest ownership

Back to all holdings Add to watchlist

Antibe Therapeutics, Inc.(Rest's ticker is and the CUSIP is 037025103. A total of 1 filers reported holding Antibe Therapeutics, Inc.(Rest in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
Fisher Asset Management, LLC ownership history of Antibe Therapeutics, Inc.(Rest
ValueSharesWeighting
Q3 2019$4,000–12,000–0.00%–
 Download
Other shareholders

There were no reported owners of Antibe Therapeutics, Inc.(Rest in Q3 2019.

NameSharesValueWeighting ↓
View complete list of Antibe Therapeutics, Inc.(Rest shareholders